Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07794670 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease

Name: Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease — clinical trial record (NCT07794670)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SPINOZA

StatusNot Yet Recruiting

PhasePhase 2

SponsorNewAmsterdam Pharma

Started2026-09

View on ClinicalTrials.gov ↗

A study evaluating Obicetrapib in adults potentially at risk for Preclinical Alzheimer's Disease

Trial Details

NCT Number	NCT07794670
Lead Sponsor	NewAmsterdam Pharma
Conditions	Preclinical Alzheimer's Disease
Enrollment	400 participants
Start Date	2026-09
Primary Completion	2028-09 (estimated)
Study Completion	2029-05 (estimated)
Updated on ClinicalTrials.gov	2026-08-31